LungBlog

Genzyme has announced  that it has entered into a license agreement with Moffitt Cancer Centre to obtain exclusive worldwide diagnostic testing rights to the discovery of the relationship of two proteins to patient response to non-small cell lung cancer (NSCLC) treatment. The expression level of these proteins may help predict how these patients will respond to therapy.

Peregrine Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection, today announced that its Phase II clinical protocol to study bavituximab in combination with chemotherapy in patients with non-small cell lung cancer (NSCLC) has been approved by the Drug Controller General of India (DCGI). The primary objective of the multi-center clinical trial is to assess the overall tumor response rate in NSCLC patients treated with the combination of bavituximab and carboplatin plus paclitaxel.

X-ray technician Rae Anne Robertson says, “If you catch it in a later stage then it’s a lot harder to treat and the prognosis isn’t as good, so we want to catch things as early as possible.”

That is something this new machine is very good at. It’s a hybrid diagnostic scanner. It fuses CT scan and PET scan technology to create a complete picture of Alvin’s lung cancer. The CT scan tells where the tumor is, and the PET scan shows what it looks like.

PhytoMedical Technologies, Inc. today announced that its patented bis-intercalator anti-cancer compound achieved a 50% or greater cancer cell kill rate in new in vitro studies of the DMS 114 strain of human small lung cancer cells, an important outcome given lung cancer’s high mortality rate and the lack of effective treatment options.

Biomoda, an Albuquerque biomedical company that has developed a non-invasive test for early detection of lung cancer, declared on 21 January that busloads of New Mexico veterans will meet state legislators on 29 January as part of “Veterans Day” in Santa Fe to push for USD1.3m in funding of an early lung cancer screening programme for veterans.

 Lung cancer didn’t stop Bonnie Addario, 60, from giving a big voice to those suffering from the same cancer as her.
The San Carlos resident began a nonprofit organization that gave more than $2.5 million in the last two years to research and provide awareness on the cancer that kills more people than any other cancer.
“There are too many people dying every day,” she said. “Four-hundred-and-fifty-five people die every day from lung cancer … That’s like an airplane crashing every day,” she said.

As far back as the Seventies, it became clear that cotton industry workers were also less at risk of lung cancer than other occupations, according to a New Scientist report.

The secret, researchers believe, is a bacterial endotoxin that contaminates raw cotton and the dust it gives off. This toxin constantly stimulates the immune system to be on guard for abnormalities.

A new clinic at Seattle Cancer Care Alliance is looking to help current and former smokers test for possible lung problems or disease in an effort to begin early detection and awareness about lung cancer.

Anti-asbestos campaigners have claimed in the past that the risk of contracting lung cancer from inhaling large quantities of crocidolite and amosite can be up to 50 times greater than with chrysotile.

DOCTORS at a Suffolk hospital are looking for patients to take part in a new lung cancer trial today.

Staff at West Suffolk Hospital in Bury St Edmunds are investigating how a blood thinning drug might help prevent blood clots in lung cancer patients.